Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolus (EOLS) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for Evolus (EOLS) over the last 7 years, with Q3 2025 value amounting to 22.15%.

  • Evolus' EBITDA Margin rose 93800.0% to 22.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.3%, marking a year-over-year increase of 20700.0%. This contributed to the annual value of 19.11% for FY2024, which is 114500.0% up from last year.
  • Per Evolus' latest filing, its EBITDA Margin stood at 22.15% for Q3 2025, which was up 93800.0% from 24.36% recorded in Q2 2025.
  • Evolus' 5-year EBITDA Margin high stood at 52.29% for Q1 2021, and its period low was 72.85% during Q3 2021.
  • For the 5-year period, Evolus' EBITDA Margin averaged around 32.52%, with its median value being 31.53% (2024).
  • In the last 5 years, Evolus' EBITDA Margin skyrocketed by 4855200bps in 2021 and then tumbled by -1042100bps in 2022.
  • Evolus' EBITDA Margin (Quarter) stood at 52.45% in 2021, then surged by 43bps to 30.09% in 2022, then surged by 37bps to 19.1% in 2023, then surged by 54bps to 8.88% in 2024, then tumbled by -150bps to 22.15% in 2025.
  • Its EBITDA Margin was 22.15% in Q3 2025, compared to 24.36% in Q2 2025 and 27.47% in Q1 2025.